Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Liquid Biopsy"" wg kryterium: Temat


Tytuł :
Liquid biopsy technologies for hematological diseases.
Autorzy :
Fu Y; Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.
Zhang Y; Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.
Khoo BL; Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.
Pokaż więcej
Źródło :
Medicinal research reviews [Med Res Rev] 2021 Jan; Vol. 41 (1), pp. 246-274. Date of Electronic Publication: 2020 Sep 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Biomedical Technology*
Liquid Biopsy*
Hematologic Diseases/*diagnosis
Hematologic Diseases/*pathology
Biomarkers/metabolism ; COVID-19/diagnosis ; Hematologic Diseases/blood ; Humans ; Microfluidics
Czasopismo naukowe
Tytuł :
Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
Autorzy :
Birkó Z; Department of Human Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Nagy B; Department of Human Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Klekner Á; Department of Neurosurgery, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Virga J; Department of Oncology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Oct 12; Vol. 21 (20). Date of Electronic Publication: 2020 Oct 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Biomarkers, Tumor*
Liquid Biopsy*/methods
Liquid Biopsy*/standards
Central Nervous System Neoplasms/*diagnosis
Glioblastoma/*diagnosis
Cell-Free Nucleic Acids ; Central Nervous System Neoplasms/etiology ; Central Nervous System Neoplasms/metabolism ; DNA, Neoplasm ; Disease Susceptibility ; Extracellular Vesicles ; Glioblastoma/etiology ; Glioblastoma/metabolism ; Humans ; Neoplastic Cells, Circulating
Czasopismo naukowe
Tytuł :
Two-site evaluation of a new workflow for the detection of malignant cells on the Sysmex XN-1000 body fluid analyzer.
Autorzy :
Favresse J; CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Université catholique de Louvain, Yvoir, Belgium.
Boland L; Hematology Laboratory, Department of Laboratory Medicine, St-Luc University Hospital and catholic University of Louvain, Brussels, Belgium.
Schellen M; Hematology Laboratory, Department of Laboratory Medicine, St-Luc University Hospital and catholic University of Louvain, Brussels, Belgium.
Fervaille C; Pathology Department, CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium.
Wuestenberghs F; Department of Gastroenterology and Hepatology, CHU UCL Namur, Godinne University Hospital, UCLouvain, Yvoir, Belgium.
Camboni A; Pathology Department, St-Luc University Hospital and catholic University of Louvain, Brussels, Belgium.
Chatelain B; CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Université catholique de Louvain, Yvoir, Belgium.
Mullier F; CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Université catholique de Louvain, Yvoir, Belgium.
Defour JP; Hematology Laboratory, Department of Laboratory Medicine, St-Luc University Hospital and catholic University of Louvain, Brussels, Belgium.; Ludwig Cancer Research and de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Jacqmin H; CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Université catholique de Louvain, Yvoir, Belgium.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2020 Oct; Vol. 42 (5), pp. 544-551. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Cytodiagnosis/*instrumentation
Cytodiagnosis/*methods
Liquid Biopsy/*instrumentation
Liquid Biopsy/*methods
Neoplasms/*diagnosis
Neoplastic Cells, Circulating/*pathology
Body Fluids ; Cytodiagnosis/standards ; Humans ; Liquid Biopsy/standards ; ROC Curve ; Retrospective Studies ; Sensitivity and Specificity ; Workflow
Czasopismo naukowe
Tytuł :
The potential of liquid biopsies in gastrointestinal cancer.
Autorzy :
Wu C; Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China.
Zhang J; Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China.
Li H; Department of Clinical Laboratory, Nantong Maternal and Child Health Care Hospital, Nantong, Jiangsu 226000, China.
Xu W; Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China.
Zhang X; Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China. Electronic address: .
Pokaż więcej
Źródło :
Clinical biochemistry [Clin Biochem] 2020 Oct; Vol. 84, pp. 1-12. Date of Electronic Publication: 2020 Jun 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Neoplasms/*diagnosis
Gastrointestinal Neoplasms/*metabolism
Liquid Biopsy/*methods
Biomarkers, Tumor/blood ; Cell-Free Nucleic Acids ; Circulating Tumor DNA ; High-Throughput Nucleotide Sequencing ; Humans ; Liquid Biopsy/trends ; Neoplastic Cells, Circulating/pathology ; Prognosis
Czasopismo naukowe
Tytuł :
[Research advance of liquid biopsy in gastrointestinal stromal tumors].
Autorzy :
Sun JY; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Gao XD; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Shen KT; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Pokaż więcej
Źródło :
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2020 Sep 25; Vol. 23 (9), pp. 917-921.
Typ publikacji :
Journal Article
MeSH Terms :
Liquid Biopsy*
Early Detection of Cancer/*methods
Gastrointestinal Neoplasms/*pathology
Gastrointestinal Stromal Tumors/*pathology
Neoplasm Recurrence, Local/*diagnosis
Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Drug Resistance, Neoplasm ; Gastrointestinal Neoplasms/blood ; Gastrointestinal Neoplasms/diagnosis ; Gastrointestinal Neoplasms/drug therapy ; Gastrointestinal Stromal Tumors/blood ; Gastrointestinal Stromal Tumors/diagnosis ; Gastrointestinal Stromal Tumors/drug therapy ; Humans ; Imatinib Mesylate/adverse effects ; Imatinib Mesylate/therapeutic use ; Neoplasm Recurrence, Local/etiology
Czasopismo naukowe
Tytuł :
Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy.
Autorzy :
Rolfo C; Thoracic Medical Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA.
Russo A; Thoracic Medical Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA.
de Miguel-Pérez D; Thoracic Medical Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
Cancer [Cancer] 2020 Sep 15; Vol. 126 (18), pp. 4089-4091. Date of Electronic Publication: 2020 May 30.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Liquid Biopsy*
Neoplasms/*genetics
Neoplasms/*pathology
Cell-Free Nucleic Acids/blood ; High-Throughput Nucleotide Sequencing ; Humans ; Phlebotomy ; Workflow
Czasopismo naukowe
Tytuł :
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
Autorzy :
Baumgartner JM; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA. .
Riviere P; Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA, USA.
Lanman RB; Guardant Health, Inc., Redwood City, CA, USA.
Kelly KJ; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA.
Veerapong J; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA.
Lowy AM; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA.
Kurzrock R; Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2020 Sep; Vol. 27 (9), pp. 3259-3267. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :
Journal Article
MeSH Terms :
Circulating Tumor DNA*/blood
Circulating Tumor DNA*/genetics
Liquid Biopsy*
Peritoneal Neoplasms*/blood
Peritoneal Neoplasms*/genetics
Peritoneal Neoplasms*/secondary
Peritoneal Neoplasms*/surgery
Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Postoperative Period ; Prognosis
Czasopismo naukowe
Tytuł :
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx.
Autorzy :
Clery E; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
Migliatico I; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy.
De Luca C; Department of Public Health, University of Naples Federico II, Naples, Italy.
Russo M; Department of Public Health, University of Naples Federico II, Naples, Italy.
De Rosa F; Department of Public Health, University of Naples Federico II, Naples, Italy.
Smeraglia F; Department of Public Health, University of Naples Federico II, Naples, Italy.
Insabato L; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Vigliar E; Department of Public Health, University of Naples Federico II, Naples, Italy.
Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
Mariconda M; Department of Public Health, University of Naples Federico II, Naples, Italy.
Gridelli C; Division of Medical Oncology, 'San Giuseppe Moscati' Hospital, Avellino, Italy.
Troncone G; Department of Public Health, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Źródło :
Diagnostic cytopathology [Diagn Cytopathol] 2020 Aug; Vol. 48 (8), pp. 759-764. Date of Electronic Publication: 2020 Apr 22.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
High-Throughput Nucleotide Sequencing*/methods
Liquid Biopsy*/methods
Adenocarcinoma of Lung/*diagnosis
Fingers/*pathology
Lung Neoplasms/*diagnosis
Adenocarcinoma of Lung/secondary ; Aged ; Cytodiagnosis/methods ; Female ; Humans ; Lung Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Diagnostic performance of blood-based liquid biopsies in hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
Autorzy :
Zhang T; Department of Medicine, Sichuan Vocational College of Health and Rehabilitation.
Yin M; Department of Cardiology, Zigong First People's Hospital, Zigong.
Wang L; School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, PR China.
Cao W; Department of Cardiology, Zigong First People's Hospital, Zigong.
Zhong S; School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, PR China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Oct 09; Vol. 99 (41), pp. e22594.
Typ publikacji :
Journal Article
MeSH Terms :
Liquid Biopsy*
Research Design*
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*pathology
Humans ; Meta-Analysis as Topic ; Systematic Reviews as Topic
Czasopismo naukowe
Tytuł :
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.
Autorzy :
Woodcock DJ; Big Data Institute, University of Oxford, Old Road Campus, Headington, Oxford, UK.
Riabchenko E; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.
Taavitsainen S; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.
Kankainen M; Medical and Clinical Genetics and Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Gundem G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brewer DS; Norwich Medical School, University of East Anglia, Norwich, UK.
Ellonen P; Institute for Molecular Medicine Finland, University of Helsinki, Tukholmankatu 8, FIN-00290, Helsinki, Finland.
Lepistö M; Institute for Molecular Medicine Finland, University of Helsinki, Tukholmankatu 8, FIN-00290, Helsinki, Finland.
Golubeva YA; Cancer Genomic Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, NCI, FNLCR, Leidos Biomedical Research, Inc, Gaithersburg, MD, USA.
Warner AC; Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
Tolonen T; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.
Jasu J; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.
Isaacs WB; Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
Emmert-Buck MR; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Avoneaux Medical Institute, Baltimore, MD, USA.
Nykter M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.
Visakorpi T; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland.; Fimlab Laboratories, Department of Pathology, Tampere University Hospital, Tampere, Finland.
Bova GS; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, FI, 33014, Finland. .
Wedge DC; Big Data Institute, University of Oxford, Old Road Campus, Headington, Oxford, UK. .; Oxford NIHR Biomedical Research Centre, Oxford, UK. .; Manchester Cancer Research Centre, University of Manchester, Manchester, UK. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Oct 08; Vol. 11 (1), pp. 5070. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Lineage*
Liquid Biopsy*
Prostatic Neoplasms/*pathology
Body Fluids/metabolism ; Chromosomes, Human, Pair 8/genetics ; Clone Cells ; DNA Copy Number Variations/genetics ; DNA, Neoplasm/genetics ; Genetic Loci ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Phylogeny
Czasopismo naukowe
Tytuł :
Improving performance of recently introduced flow cytometry-based approach of malignant cell screening in serous cavity effusion.
Autorzy :
Sun J; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Ding S; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Zhu L; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Liu Y; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Jiang Q; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Song S; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Chen W; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Li S; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Ma P; Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Medical Technology Institute, Xuzhou Medical University, Xuzhou, China.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2020 Oct; Vol. 42 (5), pp. 612-618. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Journal Article
MeSH Terms :
Body Fluids*
Cytodiagnosis/*methods
Flow Cytometry/*methods
Liquid Biopsy/*methods
Neoplasms/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Automation, Laboratory ; Child ; Cytodiagnosis/standards ; Early Detection of Cancer/methods ; Early Detection of Cancer/standards ; Female ; Flow Cytometry/standards ; Fluorescent Antibody Technique ; Humans ; Liquid Biopsy/standards ; Male ; Microscopy/methods ; Middle Aged ; ROC Curve ; Reproducibility of Results ; Young Adult
Czasopismo naukowe
Tytuł :
Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Autorzy :
Ozawa PMM; Postgraduate Program in Genetics, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil.
Jucoski TS; Postgraduate Program in Genetics, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil.
Vieira E; Postgraduate Program in Genetics, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil.
Carvalho TM; Postgraduate Program in Genetics, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil.
Malheiros D; Postgraduate Program in Genetics, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil.
Ribeiro EMSF; Postgraduate Program in Genetics, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Translational research : the journal of laboratory and clinical medicine [Transl Res] 2020 Sep; Vol. 223, pp. 40-60. Date of Electronic Publication: 2020 May 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Liquid Biopsy*
Biomarkers, Tumor/*blood
Breast Neoplasms/*diagnosis
Breast Neoplasms/*pathology
Circulating MicroRNA/*metabolism
Extracellular Vesicles/*metabolism
Breast Neoplasms/genetics ; Female ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
Traditional Diagnostics versus Disruptive Technology: The Role of the Pathologist in the Era of Liquid Biopsy.
Autorzy :
Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. .
Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. .
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Aug 15; Vol. 80 (16), pp. 3197-3199. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Liquid Biopsy*
Pathologists*
Physician's Role*
DNA, Neoplasm/*blood
Neoplasms/*diagnosis
Carcinoma, Non-Small-Cell Lung/blood ; Carcinoma, Non-Small-Cell Lung/diagnosis ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/genetics ; Genes, Tumor Suppressor ; Genes, erbB-1 ; Genes, ras ; Humans ; Lung Neoplasms/blood ; Lung Neoplasms/diagnosis ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Melanoma/drug therapy ; Melanoma/genetics ; Neoplasms/blood ; Neoplasms/drug therapy ; Neoplasms/genetics ; Pathology, Molecular ; Proto-Oncogene Proteins B-raf/genetics ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB).
Autorzy :
Rolfo C; Thoracic Oncology Department and Early Phase Clinical Trials Section, School of Medicine, Maryland University, Maryland, USA. Electronic address: .
Cardona AF; Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia.
Cristofanilli M; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 710 N Fairbanks Court, Suite 8-250A, Chicago, IL, 60611, USA.
Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Universidad Complutense and CIBERONC, Madrid, Spain.
Diaz Mochon JJ; DestiNA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Avenida de la Innovación 1, Edificio BIC, 18016, Armilla, Granada, Spain; GENYO Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government. PTS Granada - Avenida de la Ilustración, 114- 18016, Granada, Spain; Department Medicinal and Organic Chemistry, School of Pharmacy, University of Granada, Campus Cartuja s/n, 18071, Granada, Spain.
Duran I; Servicio de Oncologia Medica, Medical Oncology Department, Hospital Universitario Marques de Valdecilla, Edificio Sur, 2 Planta, Despacho 277, 39008, Santander, Spain.
Raez LE; Memorial Cancer Institute, Memorial Health Care System, Florida International University, Florida, USA.
Russo A; Thoracic Oncology Department and Early Phase Clinical Trials Section, School of Medicine, Maryland University, Maryland, USA; Medical Oncology Unit A.O. Papardo & Department of Human Pathology, University of Messina, Italy.
Lorente JA; Laboratory of Genetic Identification, Department of Legal Medicine, University of Granada, Av. de la Investigación, 11, 18071, Granada, Spain; Centre for Genomics and Oncological Research - GENYO, Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain.
Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy.
Gil-Bazo I; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain; University of Navarra, Center for Applied Medical Research, Program of Solid Tumors, Pamplona, Navarra, Spain; Idisna, Navarra Institute for Health Research, Pamplona, Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Jantus-Lewintre E; Molecular Oncology Laboratory, Fundación Investigación, Valencia General University Hospital, Valencia, Spain.
Pauwels P; Center for Oncological Research (CORE), University of Antwerp, & Department of Pathology, Antwerp University Hospital, Edegem, Belgium.
Mok T; State Key Laboratory in Oncology in South China, Hong Kong, China.
Serrano MJ; Centre for Genomics and Oncological Research - GENYO, Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain; Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs. GRANADA), Spain; Complejo Hospitalario Universitario Granada (CHUG), Department of Medical Oncology, University of Granada, Granada, Spain. Electronic address: .
Pokaż więcej
Corporate Authors :
ISLB
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Jul; Vol. 151, pp. 102978. Date of Electronic Publication: 2020 May 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cell-Free Nucleic Acids*
Liquid Biopsy*
Neoplasms/*pathology
Precision Medicine/*methods
Biomarkers, Tumor ; Humans ; Societies, Medical
Czasopismo naukowe
Tytuł :
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Autorzy :
Remon J; Department of Medical Oncology, Centro Integral Oncológico Clara Campal Barcelona (CIOCCB), HM Delfos, Barcelona, Spain. .
García-Campelo R; Department of Medical Oncology, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
de Álava E; Institute of Biomedicine of Sevilla (IBiS), Department of Normal and Pathological Cytology and Histology, Virgen del Rocio University Hospital /CSIC/University of Sevilla, Sevilla, Spain.; CIBERONC, Madrid, Spain.
Vera R; Department of Medical Oncology, Complejo Hospitalario de Navarra and Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Rodríguez-Peralto JL; CIBERONC, Madrid, Spain.; Department of Pathology, Hospital Universitario Doce de Octubre, Madrid, Spain.
Rodríguez-Lescure Á; Department of Medical Oncology, Hospital General Universitario de Elche y Vega Baja, Elche, Spain.; Group for Breast Cancer Research (GEICAM), Madrid, Spain.
Bellosillo B; CIBERONC, Madrid, Spain.; Department of Pathology, Hospital del Mar, Barcelona, Spain.
Garrido P; CIBERONC, Madrid, Spain.; School of Medicine, Universidad de Alcalá, Madrid, Spain.; Medical Oncology Department, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Rojo F; CIBERONC, Madrid, Spain.; Department of Pathology, Fundación Universitaria Jiménez Díaz, Madrid, Spain.
Álvarez-Alegret R; Department of Pathology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Pokaż więcej
Źródło :
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2020 Jun; Vol. 22 (6), pp. 823-834. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Liquid Biopsy/*standards
Medical Oncology/*standards
Neoplasms/*pathology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Consensus ; Genomics ; Humans ; Liquid Biopsy/methods ; Medical Oncology/organization & administration ; Neoplasms/genetics ; Precision Medicine ; Reproducibility of Results ; Spain
Czasopismo naukowe
Tytuł :
Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
Autorzy :
Hallal S; Department of Neurosurgical Services, Chris O'Brien Lifehouse, Camperdown 2050, Australia.; Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.; Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.; Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
Ebrahim Khani S; Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.
Wei H; Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.; Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
Lee MYT; Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.; Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
Sim HW; Department of Medical Oncology and NHMRC Clinical Trials Centre, Chris O'Brien Lifehouse, Camperdown 2050, Australia.; Central Clinical School, The University of Sydney, Sydney 2006, Australia.; The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst 2010, Australia.
Sy J; Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
Shivalingam B; Department of Neurosurgical Services, Chris O'Brien Lifehouse, Camperdown 2050, Australia.; Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.
Buckland ME; Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.; Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.; Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
Alexander-Kaufman KL; Department of Neurosurgical Services, Chris O'Brien Lifehouse, Camperdown 2050, Australia.; Discipline of Pathology, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.; Brainstorm Brain Cancer Research, Brain and Mind Centre, The University of Sydney, Camperdown 2050, Australia.; Neuropathology Department, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Jul 13; Vol. 21 (14). Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Brain Chemistry*
Liquid Biopsy*
Astrocytoma/*chemistry
Body Fluids/*chemistry
Brain Neoplasms/*chemistry
Cell-Derived Microparticles/*chemistry
Glioblastoma/*chemistry
MicroRNAs/*analysis
RNA, Neoplasm/*analysis
Astrocytoma/blood ; Astrocytoma/diagnosis ; Astrocytoma/surgery ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/blood ; Brain Neoplasms/blood ; Brain Neoplasms/diagnosis ; Brain Neoplasms/surgery ; Centrifugation, Density Gradient ; Diagnosis, Differential ; Glioblastoma/blood ; Glioblastoma/diagnosis ; Glioblastoma/surgery ; High-Throughput Nucleotide Sequencing ; Humans ; MicroRNAs/blood ; Neoplasm Grading ; Neurosurgical Procedures ; Organ Specificity ; RNA, Neoplasm/blood ; RNA, Small Interfering/analysis ; RNA, Small Interfering/blood ; RNA-Seq ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
Autorzy :
Le Rhun E; Department of Neurology & Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland; University of Lille, U-1192, F-59000 Lille, France; Inserm, U-1192, F-59000 Lille, France; CHU Lille, Neuro-Oncology, General and Stereotaxic Neurosurgery Service, F-59000 Lille, France; Oscar Lambret Center, Neurology, F-59000 Lille, France.
Seoane J; Vall D'Hebron Institute of Oncology (VHIO), Vall D'Hebron University Hospital (HUVH), Universitat Autònoma de Barcelona. Institució Catalana de Recerca I Estudis Avançats (ICREA), CIBERONC, Barcelona, Spain.
Salzet M; University of Lille, Inserm, U-1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, Lille, F-59000, France.
Soffietti R; Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy.
Weller M; Department of Neurology & Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2020 Jun 28; Vol. 480, pp. 24-28. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor*/blood
Biomarkers, Tumor*/cerebrospinal fluid
Biomarkers, Tumor*/urine
Liquid Biopsy*
Brain Neoplasms/*diagnosis
Brain Neoplasms/pathology ; Cell-Free Nucleic Acids/blood ; Humans ; Isocitrate Dehydrogenase/genetics ; MicroRNAs/blood ; MicroRNAs/cerebrospinal fluid ; Mutation ; Neoplastic Cells, Circulating/pathology ; RNA, Messenger/blood ; RNA, Messenger/cerebrospinal fluid
Czasopismo naukowe
Tytuł :
Exosome-based liquid biopsies in cancer: opportunities and challenges.
Autorzy :
Yu W; Exosome Diagnostics, Inc., a Bio-Techne brand, Waltham, USA.
Hurley J; Exosome Diagnostics, Inc., a Bio-Techne brand, Waltham, USA.
Roberts D; Exosome Diagnostics, Inc., a Bio-Techne brand, Waltham, USA.
Chakrabortty SK; Exosome Diagnostics, Inc., a Bio-Techne brand, Waltham, USA.
Enderle D; Exosome Diagnostics GmbH, a Bio-Techne brand, Martinsried, Germany.
Noerholm M; Exosome Diagnostics GmbH, a Bio-Techne brand, Martinsried, Germany.
Breakefield XO; Department of Neurology, Massachusetts General Hospital, Boston, USA; Neuroscience Program, Harvard Medical School, Boston, USA.
Skog JK; Exosome Diagnostics, Inc., a Bio-Techne brand, Waltham, USA. Electronic address: .
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Apr; Vol. 32 (4), pp. 466-477. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Circulating Tumor DNA*
Exosomes*
Neoplastic Cells, Circulating*
Biomarkers, Tumor ; Humans ; Liquid Biopsy ; Male ; Neoplasm Recurrence, Local
Czasopismo naukowe
Tytuł :
Microfluidic detection of human diseases: From liquid biopsy to COVID-19 diagnosis.
Autorzy :
Jiang K; Mechanobiology Institute, National University of Singapore, Singapore.
Jokhun DS; Department of Biomedical Engineering, National University of Singapore, Singapore.
Lim CT; Mechanobiology Institute, National University of Singapore, Singapore; Department of Biomedical Engineering, National University of Singapore, Singapore; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore. Electronic address: .
Pokaż więcej
Źródło :
Journal of biomechanics [J Biomech] 2021 Mar 05; Vol. 117, pp. 110235. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19 Testing*
Point-of-Care Testing*
COVID-19/*diagnosis
Liquid Biopsy/*methods
Microfluidics/*methods
Biomarkers ; Circulating Tumor DNA ; Exosomes ; Humans ; Lab-On-A-Chip Devices ; Machine Learning ; Neoplasms/diagnosis ; Neoplastic Cells, Circulating
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies